Experimental Rx Helped Lung Cancer Patients Live for Years
Lung cancer is the leading cause of cancer-related death in the US. Advanced lung cancers have spread to other areas of the body and are extremely tough to beat. An experimental therapy may be a game changer.
How Researchers Wiped Out Triple-Negative Breast Cancer
Triple-negative breast cancer is a fast-growing form of the disease that tends to return (recur). But a fresh therapeutic approach was found to be capable of eliminating the disease altogether.
Dual Rx Therapy Stalled Pancreatic Cancer
Good news on the pancreatic cancer front has been slow for some time now. But the situation may have changed, as a new study suggests that a combination of two medications may improve the outlook for patients whose pancreatic cancer has spread.
New Life For Advanced Cancer Patients
Gemzar (gemcitabine) is the standard of care for pancreatic cancer. Results from a trial showed that adding another medication worked even better.
Breast Cancer Drug on Route for Melanoma
A phase III trial for a melanoma treatment drug, which is already on the market for breast and lung cancer, has shown promise. The next step is Food and Drug Administration approval for melanoma.
Newer, More Expensive Drugs Not Better
After the long process of designing, developing and testing new drugs, these meds are usually far more expensive than the older medications on the market. Are they better? Not always.
Billionths of a Meter Cancer Drugs
Nanomedicine is the latest answer to the ancient dilemma of finding the best way to deliver a drug. Skipping the stomach with intravenous drugs is one shortcut, but getting a drug from the bloodstream into a cell is even more complicated.
Dual Therapies for Treating Pancreatic Cancer
Currently, there's only one chemotherapy agent being used to treat pancreatic cancer. Gemzar (gemcitabine) works for some patients, but not others.